UL
Unilever PLC
NYSE · Consumer Defensive · Household & Personal Products · GB
$64.34
+0.15%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 105.6B | 50.5B | 60.8B | 59.6B | 60.1B |
| Cost of Revenue | — | 26.8B | — | 34.4B | 35.9B |
| Gross Profit | 105.8B | 50.5B | 60.8B | 25.2B | 24.2B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | 949.0M | 908.0M |
| SG&A Expense | 93.0M | 13.6B | 71.0M | 15.1B | 14.4B |
| General & Admin Expense | 36.0M | 13.6B | 6.7B | 6.6B | 6.6B |
| Selling & Marketing Expense | — | — | 9.4B | 8.5B | 7.8B |
| Other Expenses | 87.2B | (42.0M) | 51.3B | (666.0M) | (1.9B) |
| Total Operating Expenses | 87.3B | 13.6B | 51.4B | 15.4B | 13.4B |
| Cost and Expenses | 87.8B | 40.4B | 51.4B | 49.8B | 49.3B |
| Operating Income (EBIT) | 17.8B | 9.0B | 9.4B | 9.8B | 10.8B |
| Non-Operating | |||||
| Interest Income | 401.0M | 382.3M | 438.0M | 442.0M | 281.0M |
| Interest Expense | 1.7B | 983.6M | 1.1B | 1.1B | 789.0M |
| Net Interest Income | (1.3B) | (601.3M) | (680.0M) | (633.0M) | (508.0M) |
| Other Non-Op Income/Expense | (1.2B) | (343.0M) | (531.0M) | (419.0M) | (418.0M) |
| Non-Operating Income (excl Interest) | (2.4B) | — | (1.8B) | (362.0M) | 1.2B |
| EBT (Pre-Tax Income) | 16.6B | 8.7B | 8.9B | 9.3B | 10.3B |
| Income Tax Expense | 4.8B | 2.5B | 2.5B | 2.2B | 2.1B |
| Bottom Line | |||||
| Net Income | 11.2B | 9.5B | 5.7B | 6.5B | 7.6B |
| Earnings from Cont. Ops | 11.9B | 6.2B | 6.4B | 7.1B | 8.3B |
| Earnings from Discont. Ops | 403.8M | 3.8B | — | — | — |
| Bottom Line Net Income | 11.2B | 5.9B | 5.7B | 6.5B | 7.6B |
| Per Share | |||||
| Basic EPS | $4.82 | $2.68 | $2.29 | $2.56 | $3.00 |
| Diluted EPS | $4.82 | $2.59 | $2.29 | $2.56 | $2.99 |
| Revenue Per Share | $48.56 | $23.12 | $24.24 | $23.54 | $23.50 |
| Shares | |||||
| Basic Shares Outstanding | 2.2B | 2.2B | 2.5B | 2.5B | 2.6B |
| Diluted Shares Outstanding | 2.2B | 2.2B | 2.5B | 2.5B | 2.6B |
| Profitability Metrics | |||||
| EBITDA | 23.1B | 11.5B | 13.0B | 11.1B | 10.6B |
| D&A | 2.9B | 1.3B | 1.8B | 990.0M | 1.1B |
| EBIT | 20.2B | 9.7B | 11.3B | 10.1B | 9.5B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026